Perspectives
Judas Priest guitarist opens up about Parkinson’s diagnosis
The heavy metal guitarist released a message on social media
READ MORE
Prep:
Cook:
Serves:
Tekes, the Finnish Funding Agency for Innovation, has granted a €2,903,000 loan to Herantis Pharma Plc to support its clinical study of CDNF for the treatment of Parkinson’s disease. The loan was granted conditionally, subject to obtaining regulatory approval for the clinical study.
Pekka Simula, CEO of Herantis Pharma, added: “We are very excited about our opportunity to translate the results of years of leading academic research to clinical stage, hopefully for the benefit of as many patients as possible.”
Herantis aims to start its clinical development programme with regulatory submissions in Finland and Sweden by the end of 2015. Patient treatments are expected to begin in the first half of 2016. The company expects to recruit 18 patients with Parkinson’s disease in this first-in-human study of CDNF.
The heavy metal guitarist released a message on social media
READ MORE
How a New York dance class spread around the world
READ MORE
Self-taught artist Walter Reynecke on how painting calms his condition
READ MORE
Comments